|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.180 USD | +7.85% |
|
+12.16% | -23.33% |
| 06-19 | TSX dips on Middle East conflict concerns | RE |
| 06-18 | Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering | MT |
| Capitalization | 2.28B 1.99B 1.87B 1.7B 3.14B 198B 3.54B 22.07B 8.52B 90.37B 8.57B 8.39B 333B | P/E ratio 2025 * |
11.7x | P/E ratio 2026 * | 5.11x |
|---|---|---|---|---|---|
| Enterprise value | 21.45B 18.71B 17.57B 15.98B 29.47B 1,863B 33.24B 207B 80.04B 849B 80.5B 78.78B 3,126B | EV / Sales 2025 * |
2.14x | EV / Sales 2026 * | 1.92x |
| Free-Float |
88.99% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Bausch Health Companies Inc.
More recommendations
More press releases
More news
| 1 day | +7.85% | ||
| 1 week | +12.16% | ||
| Current month | +36.42% | ||
| 1 month | +33.19% | ||
| 3 months | -11.71% | ||
| 6 months | -16.37% | ||
| Current year | -23.33% |
| 1 week | 5.68 |  | 6.31 |
| 1 month | 4.41 | | 6.31 |
| Current year | 4.25 | | 8.28 |
| 1 year | 3.96 | | 9.85 |
| 3 years | 3.96 | | 11.46 |
| 5 years | 3.96 | | 34.8 |
| 10 years | 3.96 | | 263.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 62 | 2022-05-09 |
| Director of Finance/CFO | 59 | 2024-08-18 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Power
CHM | Chairman | 68 | 2022-05-09 |
Thomas Appio
BRD | Director/Board Member | 62 | 2022-05-09 |
Amy Wechsler
BRD | Director/Board Member | 55 | 2016-06-13 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.26% | 21 M€ | +0.15% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.85% | +12.16% | -4.48% | -16.03% | 2.28B | ||
| -0.78% | -3.33% | -11.94% | +169.86% | 705B | ||
| -1.08% | -3.79% | +3.49% | -11.05% | 363B | ||
| -0.24% | -5.93% | -50.38% | +30.75% | 333B | ||
| +0.01% | -3.60% | +8.25% | +34.14% | 328B | ||
| -0.19% | -4.62% | +4.08% | -14.29% | 255B | ||
| +0.02% | -2.92% | +1.37% | +20.55% | 228B | ||
| +0.51% | -4.33% | -14.49% | +6.33% | 220B | ||
| +1.29% | -3.09% | -38.05% | -6.30% | 199B | ||
| -0.19% | -2.62% | -5.39% | +23.34% | 156B | ||
| Average | +0.73% | -1.29% | -10.75% | +23.73% | 278.73B | |
| Weighted average by Cap. | -0.25% | -3.32% | -11.30% | +50.91% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.01B 8.73B 8.2B 7.46B 13.75B 869B 15.51B 96.75B 37.35B 396B 37.57B 36.76B 1,459B | 10.29B 8.98B 8.43B 7.67B 14.14B 894B 15.95B 99.48B 38.41B 407B 38.63B 37.8B 1,500B |
| Net income | 257M 224M 210M 191M 353M 22.31B 398M 2.48B 958M 10.16B 964M 943M 37.43B | 473M 413M 388M 353M 650M 41.11B 733M 4.57B 1.77B 18.73B 1.78B 1.74B 68.99B |
| Net Debt | 19.17B 16.71B 15.7B 14.28B 26.33B 1,665B 29.7B 185B 71.52B 758B 71.93B 70.39B 2,794B | 17.53B 15.28B 14.36B 13.06B 24.08B 1,522B 27.16B 169B 65.4B 694B 65.77B 64.37B 2,554B |
More financial data
* Estimated data
Employees
20,700
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-18 | 6.180 $ | +7.85% | 4,649,649 |
| 25-06-17 | 5.730 $ | -3.05% | 2,231,188 |
| 25-06-16 | 5.910 $ | -1.17% | 5,110,534 |
| 25-06-13 | 5.980 $ | +8.53% | 11,500,118 |
| 25-06-12 | 5.510 $ | +3.38% | 4,208,753 |
Delayed Quote Nyse, June 18, 2025 at 04:10 pm
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
6.180USD
Average target price
7.083USD
Spread / Average Target
+14.62%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition